WBCPI 100.32 0.0% CBA 147.26 1.2375% BHP 42.99 0.9155% RIO 121.66 1.9099% CSL 283.39 -0.819% NAB 39.33 0.2038% WBC 31.51 -2.3249% ANZ 31.71 1.4071% MQG 229.52 1.6205% WES 67.64 -0.0591% NEM 66.41 -4.2532% SQ2 118.96 3.5335% GMG 35.34 -2.4296% FMG 19.5 3.2839% RMD 37.0 -2.194% WDS 24.25 3.2354% TLS 3.88 0.2584% WTC 124.87 2.0013% ALL 63.17 0.0317% TCL 12.66 -1.0164%
Last update at 2024-11-07T05:10:00Z
Top Dividend Stocks On ASX Featuring Australian United Investment And 2 More
Wed 02 Oct 24, 07:08 PMSantos (ASX:STO) Appoints New CFO Sherry Duhe, Reports Strong Dividend and Project Advancements
Mon 23 Sep 24, 08:11 AMAnalysts Have Made A Financial Statement On Santos Limited's (ASX:STO) Half-Year Report
Fri 23 Aug 24, 12:31 AMA Look At The Fair Value Of Santos Limited (ASX:STO)
Wed 21 Aug 24, 10:54 PMNatural Gas Demand Will Remain Strong After 2050, Santos Says
Wed 21 Aug 24, 05:08 AMSantos Boss Is Racing Against Time to Build a Gas Giant
Sat 06 Jul 24, 11:01 PMAramco, Adnoc Are Considering Bids for Gas Producer Santos
Thu 04 Jul 24, 04:43 AMSantos (ASX:STO) shareholders have earned a 5.8% CAGR over the last five years
Thu 04 Apr 24, 10:22 PMShould Income Investors Look At Santos Limited (ASX:STO) Before Its Ex-Dividend?
Fri 23 Feb 24, 08:57 PMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 2948.00M | 1205.00M | -306.00000M | 1018.00M | 1106.00M |
Minority interest | - | - | - | - | - |
Net income | 2112.00M | 658.00M | -357.00000M | 674.00M | 630.00M |
Selling general administrative | 139.00M | 72.00M | 83.00M | 54.00M | 75.00M |
Selling and marketing expenses | 19.00M | 10.00M | 10.00M | 12.00M | 14.00M |
Gross profit | 5637.00M | 2974.00M | 1759.00M | 2318.00M | 2014.00M |
Reconciled depreciation | 1747.00M | 1243.00M | 1317.84M | 1427.35M | 945.03M |
Ebit | 3367.00M | 1409.00M | 24.00M | 1313.00M | 1364.00M |
Ebitda | 5114.00M | 2652.00M | 1039.00M | 2313.00M | 2309.03M |
Depreciation and amortization | 1747.00M | 1243.00M | 1015.00M | 1000.00M | 945.03M |
Non operating income net other | - | - | - | - | - |
Operating income | 3367.00M | 1409.00M | 24.00M | 1313.00M | 1083.00M |
Other operating expenses | 4500.00M | 3232.00M | 3619.00M | 2987.00M | 2577.00M |
Interest expense | 272.00M | 204.00M | 232.00M | 295.00M | 258.00M |
Tax provision | 836.00M | 547.00M | 66.22M | 344.00M | 476.00M |
Interest income | 54.00M | 5.00M | 19.48M | 52.81M | 42.50M |
Net interest income | -254.00000M | -217.00000M | -281.74500M | -368.25578M | -323.03769M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 836.00M | 547.00M | 51.00M | 344.00M | 476.00M |
Total revenue | 7790.00M | 4713.00M | 3387.00M | 4033.00M | 3660.00M |
Total operating expenses | 2347.00M | 1493.00M | 1991.00M | 1272.00M | 931.00M |
Cost of revenue | 2153.00M | 1739.00M | 1628.00M | 1715.00M | 1646.00M |
Total other income expense net | -419.00000M | -204.00000M | -330.00000M | -295.00000M | 23.00M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 2112.00M | 658.00M | -463.51597M | 962.03M | 892.60M |
Net income applicable to common shares | 2112.00M | 658.00M | -357.00000M | 674.00M | 630.00M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Total assets | 29756.00M | 28856.00M | 30009.00M | 17656.00M | 16509.00M |
Intangible assets | 1.00M | - | - | - | - |
Earning assets | - | - | - | - | - |
Other current assets | 86.00M | 75.00M | 122.00M | 23.00M | 23.00M |
Total liab | 14481.00M | 14013.00M | 16399.00M | 10429.00M | 8833.00M |
Total stockholder equity | 15275.00M | 14843.00M | 13610.00M | 7227.00M | 7676.00M |
Deferred long term liab | - | - |